Literature DB >> 19455465

Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.

Clive S Zent1, Tait Shanafelt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455465     DOI: 10.1080/10428190902919226

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  6 in total

Review 1.  Autoimmune complications in chronic lymphocytic leukaemia (CLL).

Authors:  Clive S Zent; Neil E Kay
Journal:  Best Pract Res Clin Haematol       Date:  2010-03       Impact factor: 3.020

2.  Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone.

Authors:  Deborah A Bowen; Timothy G Call; Tait D Shanafelt; Neil E Kay; Susan M Schwager; Megan S Reinalda; Kari G Rabe; Susan L Slager; Clive S Zent
Journal:  Leuk Lymphoma       Date:  2010-04

Review 3.  Chronic lymphocytic leukemia and autoimmunity: a systematic review.

Authors:  Kate Hodgson; Gerardo Ferrer; Emili Montserrat; Carol Moreno
Journal:  Haematologica       Date:  2011-01-17       Impact factor: 9.941

4.  Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited.

Authors:  Ana Vagos Mata; Eduardo Espada; Daniela Alves; Blanca Polo; Maria João Costa; Conceição Lopes; João F Lacerda; João Raposo
Journal:  Cancer Med       Date:  2021-11-16       Impact factor: 4.452

5.  The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemia.

Authors:  Luca Laurenti; Barbara Vannata; Idanna Innocenti; Francesco Autore; Francesco Santini; Simona Sica; Dimitar G Efremov
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-04-10       Impact factor: 2.576

Review 6.  Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.

Authors:  Pavankumar Tandra; Jairam Krishnamurthy; Vijaya Raj Bhatt; Kam Newman; James O Armitage; Mojtaba Akhtari
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.